Matches in Wikidata for { <http://www.wikidata.org/entity/Q91824649> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- Q91824649 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91824649 description "scientific article published on 04 May 2019" @default.
- Q91824649 description "wetenschappelijk artikel" @default.
- Q91824649 description "наукова стаття, опублікована 4 травня 2019" @default.
- Q91824649 name "Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study" @default.
- Q91824649 name "Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study" @default.
- Q91824649 type Item @default.
- Q91824649 label "Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study" @default.
- Q91824649 label "Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study" @default.
- Q91824649 prefLabel "Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study" @default.
- Q91824649 prefLabel "Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study" @default.
- Q91824649 P1433 Q91824649-338A04CC-E63C-4475-865A-75F3ED4E91A2 @default.
- Q91824649 P1476 Q91824649-7E27ADC7-95E1-496B-871D-37A4B2AD404F @default.
- Q91824649 P2093 Q91824649-11DB8522-A83C-4CEF-B7F6-75DB1E7C6EB9 @default.
- Q91824649 P2093 Q91824649-2981C7B3-4F4D-402C-9BB0-7B4783E1D3EC @default.
- Q91824649 P2093 Q91824649-35265496-841C-44C0-B4F1-B2844E39E36C @default.
- Q91824649 P2093 Q91824649-700021A6-2F39-4A99-A644-329B63A31F33 @default.
- Q91824649 P2093 Q91824649-74ADD754-877C-436F-A226-F71566346575 @default.
- Q91824649 P2093 Q91824649-80374DC5-06BC-4955-8CEB-AFE119851F82 @default.
- Q91824649 P2093 Q91824649-82CCBB41-1657-4580-9869-648F0D993F55 @default.
- Q91824649 P2093 Q91824649-843E8B8D-EEE4-48ED-BF0F-64A245D2D5EA @default.
- Q91824649 P2093 Q91824649-93CB511A-97DA-4174-8631-F3070F4B2C34 @default.
- Q91824649 P2093 Q91824649-9B57D0F2-C73E-4DC7-A421-77A0598E43B1 @default.
- Q91824649 P2093 Q91824649-AD4D71D9-F842-4DDB-BAA2-BBA1A14CA01F @default.
- Q91824649 P2093 Q91824649-B27F0235-FE8E-4BCE-BA87-5682C665A53D @default.
- Q91824649 P2093 Q91824649-B8C182C8-5BA6-489A-B975-F654085B8F5B @default.
- Q91824649 P2093 Q91824649-CADF6B5D-791E-43BB-8868-9C58C0496A7A @default.
- Q91824649 P2093 Q91824649-CB5E13DC-4163-47C5-8DA0-FC6E5CA23D64 @default.
- Q91824649 P2093 Q91824649-CC9BFA19-F115-47A3-8482-9306B7BB85EF @default.
- Q91824649 P2093 Q91824649-D9652A6E-A8B2-4C2A-9835-948EE95898A0 @default.
- Q91824649 P2093 Q91824649-F741CD63-0FD8-4231-B3C4-2D2CEDDC3A07 @default.
- Q91824649 P2093 Q91824649-F7AA4A04-217E-4E8C-BC8C-42A0D20118A3 @default.
- Q91824649 P2093 Q91824649-FB2415EA-BB56-4AB9-8473-54149A932CCE @default.
- Q91824649 P304 Q91824649-0C4DFF12-93E1-438D-A1BC-A3CF885DF48F @default.
- Q91824649 P31 Q91824649-2A877C6E-FCCD-485C-8D54-FB87DE656BF9 @default.
- Q91824649 P356 Q91824649-AF693E4E-A202-4655-8EAF-8BB12CCA3E86 @default.
- Q91824649 P433 Q91824649-6B7BE6E9-EDF5-42BC-9427-13822FFE8B5F @default.
- Q91824649 P478 Q91824649-63A793DE-71B7-4CE1-9719-624BE2C8BDFF @default.
- Q91824649 P50 Q91824649-37815F51-8F04-4F07-BF77-C0F60B282225 @default.
- Q91824649 P50 Q91824649-94061933-B0EE-4B0A-9381-3854DF5FF17E @default.
- Q91824649 P577 Q91824649-D225DDBF-6EC8-4985-99E0-59777EE8D13D @default.
- Q91824649 P698 Q91824649-935CD510-0922-4042-B987-F79B9D48A119 @default.
- Q91824649 P921 Q91824649-37A6AF35-B129-4BE2-9857-F3CCCA0E6883 @default.
- Q91824649 P921 Q91824649-9A4C65C1-FDCE-491E-A1DB-66EE2030C82F @default.
- Q91824649 P356 J.JTHO.2019.04.026 @default.
- Q91824649 P698 31063862 @default.
- Q91824649 P1433 Q2448056 @default.
- Q91824649 P1476 "Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study" @default.
- Q91824649 P2093 "Andy Mammen" @default.
- Q91824649 P2093 "Anish Thomas" @default.
- Q91824649 P2093 "Christopher Trindade" @default.
- Q91824649 P2093 "Elliot Levy" @default.
- Q91824649 P2093 "Faye Yin" @default.
- Q91824649 P2093 "Howard A Young" @default.
- Q91824649 P2093 "Javed Khan" @default.
- Q91824649 P2093 "Jung-Min Lee" @default.
- Q91824649 P2093 "Liqiang Xi" @default.
- Q91824649 P2093 "Mark Raffeld" @default.
- Q91824649 P2093 "Nitin Roper" @default.
- Q91824649 P2093 "Rasa Vilimas" @default.
- Q91824649 P2093 "Rebecca Erwin-Cohen" @default.
- Q91824649 P2093 "Samantha Nichols" @default.
- Q91824649 P2093 "Seth M Steinberg" @default.
- Q91824649 P2093 "Stephen Hewitt" @default.
- Q91824649 P2093 "Vamsidhar Velcheti" @default.
- Q91824649 P2093 "Venkatesh Krishnasamy" @default.
- Q91824649 P2093 "Yuanbin Chen" @default.
- Q91824649 P2093 "Yves Pommier" @default.
- Q91824649 P304 "1447-1457" @default.
- Q91824649 P31 Q13442814 @default.
- Q91824649 P356 "10.1016/J.JTHO.2019.04.026" @default.
- Q91824649 P433 "8" @default.
- Q91824649 P478 "14" @default.
- Q91824649 P50 Q111692206 @default.
- Q91824649 P50 Q69483163 @default.
- Q91824649 P577 "2019-05-04T00:00:00Z" @default.
- Q91824649 P698 "31063862" @default.
- Q91824649 P921 Q19000544 @default.
- Q91824649 P921 Q7083106 @default.